Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;36(5):506-517.
doi: 10.1177/10436596251345338. Epub 2025 Jun 28.

Cross-Cultural Adaptation of the Breast Cancer and Lymphedema Symptom Experience Index in Bengali

Affiliations

Cross-Cultural Adaptation of the Breast Cancer and Lymphedema Symptom Experience Index in Bengali

Vincent Singh Paramanandam et al. J Transcult Nurs. 2025 Sep.

Abstract

Introduction: Breast cancer-related lymphedema is associated with a myriad of distressing symptoms and significantly impacts survivors' quality of life. The Breast Cancer-related Lymphedema Symptom Experience Index (BCLE-SEI) is a validated patient-reported outcome measure (PROM), but is unavailable in Indian languages. This study aimed to cross-culturally adapt the BCLE-SEI into the Bengali language.

Method: Following established guidelines, the BCLE-SEI was translated, back-translated, and validated in 168 Bengali-speaking women with or at risk of lymphedema.

Results: Content validity was confirmed by ≥98% of participants. Exploratory factor analysis identified two factors in symptom occurrence and distress subscales, explaining 43.9% and 51% of the variance, respectively. Internal consistency (α) was >0.85, and construct validity was supported with over 50% of predefined hypotheses met. Test-retest reliability (intraclass correlation coefficient [ICC2,1]) was .46 (95% confidence interval [CI] = [-0.2, 0.8], p = .076).

Discussion: The BCLE-SEI-Bengali is a reliable and valid PROM for assessing lymphedema-related symptoms for Bengali-speaking women.

Keywords: Breast Cancer–related Lymphedema and Symptom Experience Index (BCLE-SEI); breast cancer; lymphedema; patient-reported outcome measures (PROM); symptoms.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Aaronson N. K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N. J., Filiberti A., Flechtner H., Fleishman S. B., Dehaes J., Kaasa S., Klee M., Osoba D., Razavi D., Rofe P. B., Schraub S., Sneeuw K., Sullivan M., Takeda F. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. 10.1093/jnci/85.5.365 - DOI - PubMed
    1. Anand A., Mishra A., Damde H., Saxena A., Yadav S. K., Sharma D. (2022). Molecular profile and clinico-pathological characteristics of breast cancer in Central India: First Investigative Report. Indian Journal of Surgical Oncology, 13(2), 421–425. 10.1007/s13193-022-01502-0 - DOI - PMC - PubMed
    1. Anthoine E., Moret L., Regnault A., Sébille V., Hardouin J.-B. (2014). Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures. Health and Quality of Life Outcomes, 12, 2. 10.1186/s12955-014-0176-2 - DOI - PMC - PubMed
    1. Bhargavan R. V., Prasannan N., Krishna K. M. J., Augustine P., Cherian K. (2024). The role of level III dissection in locally advanced breast cancer following neoadjuvant chemotherapy-A prospective study. South Asian Journal of Cancer, 13(3), 170–176. 10.1055/s-0043-1777727 - DOI - PMC - PubMed
    1. Bray F., Laversanne M., Sung H., Ferlay J., Siegel R. L., Soerjomataram I., Jemal A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. 10.3322/caac.21834 - DOI - PubMed

LinkOut - more resources